Pune, Sept 21(TVN) : The Serum Institute of India has informed the Centre that it will be able to supply around 22 crore doses of Covishield in October as the Union government has announced resuming export of surplus Covid vaccines in the coming fourth quarter under the ‘Vaccine Maitri’ programme.
In a communication to the Centre Prakash Kumar Singh, Director, Government and Regulatory Affairs at Serum Institute of India (SII), said the firm has enhanced its production capacity of Covishield and it will be able to supply 21.90 crore doses in October to Government of India and private hospitals.
The Pune-based pharmaceutical company has enhanced the manufacturing capacity of Covishield to more than 20 crore doses per month.
Starting from January 2021, we have supplied 66.33 crore doses of Covishield to MoHFW, Government of India in addition to supply of more than 7.77 crore doses to state governments and private hospitals till 19th September 2021 evening.
All this has become possible under the dynamic leadership and kind direction of the Prime Minister Narendra Modi, continuous support from team Ministry of Health and GoI, visionary leadership of the companys CEO, Dr Adar C Poonawalla, along with untiring efforts of Team SIIPL,” a source quoted Singh as having communicated.
Singh futher assured that by December 31, keeping with the timeline, the firm will complete the recent supply order of 66 crore doses.
7x5pjg85n7|100057829174tblpage|Content
7x5pjg85n8|000057829174|__vabriant|tblpage|Content|B13BC9CC-749A-496E-826E-1C6ECF01FFDA